BioStem Technologies (BSEM) vs Tevogen (TVGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioStem Technologies (BSEM) has outperformed Tevogen (TVGN) over the past year, losing 50.5% versus a loss of 82.5%. BioStem Technologies is the larger company by market cap ($45.4 million vs $43.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSEM | TVGN |
|---|---|---|
| Share price | $2.43 | $6.68 |
| Market cap | $45.37M | $43.50M |
| 1-day change | +1.67% | +2.93% |
| YTD return | -37.27% | -60.79% |
| 1-year return | -50.52% | -82.51% |
| 5-year return | +70.71% | — |
| P/E ratio (TTM) | 2.76 | — |
| Forward P/E | 8.38 | — |
| EPS (TTM) | $0.88 | $-6.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $39.00 |
| 52-week low | $2.25 | $3.64 |
| Distance from 52-week high | -71.07% | -82.87% |
| Average volume | 120.39K | 9.75K |
| Shares outstanding | 18.67M | 6.51M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BSEM has outperformed TVGN by 32.0 percentage points over the past year.
BSEM vs TVGN FAQ
Which is bigger, BioStem Technologies or Tevogen?
BioStem Technologies (BSEM) is larger, with a market capitalization of $45.37M compared with $43.50M for Tevogen (TVGN).
Which stock has performed better over the past year, BSEM or TVGN?
BSEM returned -50.52% over the past 12 months, compared with -82.51% for TVGN (price return, excluding dividends). Past performance does not predict future results.
Are BioStem Technologies and Tevogen in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.